Dendrite Japan Rolls Out Sales Force Effectiveness Tools at Four Major Japanese Pharmaceutical Companies.Business Editors MORRISTOWN, N.J.--(BUSINESS WIRE)--June 27, 2001 More Than 3,500 Sales Force Personnel at Teijin Ltd., Tsumura & Co., Ono Pharmaceutical, and Dainippon Pharmaceutical Co., Ltd. Begin Using Dendrite's j-ForceWeb(TM) Product Dendrite dendrite: see nervous system; synapse. (NASDAQ/NMS: DRTE DRTE Defence Research Telecommunications Establishment ), the visionary innovator in global pharmaceutical technology, today announced that more than 3,500 sales representatives, managers, and head office users from some of Japan's largest and most respected pharmaceutical companies -- Teijin Ltd., Tsumura & Co., Ono Pharmaceutical, and Dainippon Pharmaceutical Co. -- have begun using Dendrite's j-ForceWeb(TM) product, following recent rollouts. Dendrite's j-forceWEB(TM) is a comprehensive, Web-enabled suite of sales force effectiveness tools for the Japanese pharmaceutical market. It provides sales force personnel with a single, centralized cen·tral·ize v. cen·tral·ized, cen·tral·iz·ing, cen·tral·iz·es v.tr. 1. To draw into or toward a center; consolidate. 2. location from which to access product information, analyze sales information, record activity data, and access physician and institution databases. More than 13,000 sales representatives in Japan are currently using the j-ForceWEB(TM) system. With approximately 100 employees, Dendrite Japan provides pharmaceutical companies with a comprehensive array of consulting services and support for products such as PharmaNet-Connect(TM), a Web-based focused, cohesive, and easy-to-use single point of contact for all internal pharmaceutical sales and marketing communications Marketing communications (or marcom) are messages and related media used to communicate with a market. Those who practice advertising, branding, direct marketing, graphic design, marketing, packaging, promotion, publicity, sponsorship, public relations, sales, sales . To meet the increasing requirements of the pharmaceutical industry in that country, Dendrite Japan's Osaka office has moved to larger quarters at Dosho-machi, Osaka, which now houses its operational, R&D, and computer centers. In May, Dendrite Japan's Tokyo office moved to larger facilities at Kanda, Tokyo See also Kanda, Fukuoka and the disambiguation page for Kanda. Kanda神田 ( . "A growing number of pharmaceutical companies in Japan are using Dendrite pharmaceutical solutions such as j-ForceWeb(TM), and our facilities have expanded to better serve that market," said Jean-Paul Modde, Vice President, Asia/Pacific. "Our new Osaka and Tokyo facilities are also centrally located near many of our clients. This will enable us to better serve them." About Dendrite Dendrite, the visionary innovator in global pharmaceutical technology, helps clients strategically manage their customer relationships to increase market share. Dendrite creates unique, analytically driven solutions that enable pharmaceutical companies to influence prescriber behavior, thereby delivering a sustained competitive advantage. For more information, visit the company's website at http://www.dendrite.com. About Teijin Ltd. Headquartered in Tokyo and established in 1918, Teijin Ltd. operates in fibers, films and plastics, pharmaceuticals and medical products, machinery and plants, new products, and other business segments. About Tsumura & Co. Founded in 1893, Tsumura & Co. is the world's largest producer of herbal medicines herbal medicine, use of natural plant substances (botanicals) to treat and prevent illness. The practice has existed since prehistoric times and flourishes today as the primary form of medicine for perhaps as much as 80% of the world's population. , annually converting more than 5,000 tons of herbs into herbal products worth $555 million (1997 Kampo sales). The company is based in Tokyo. About Ono Pharmaceutical Co., Ltd. Founded in 1717 and headquartered in Osaka, Japan, Ono Pharmaceutical specializes in its own research and development. Its primary research fields are Prostaglandins Prostaglandins Prostaglandins are produced by the body and are responsible for inflammation features, such as swelling, pain, stiffness, redness and warmth. , Enzyme Inhibition Enzyme inhibition The prevention of an enzymic process as a result of the interaction of some substance with an enzyme so as to decrease the rate of the enzymic reaction. The substance causing such an effect is termed an inhibitor. , Neuroscience neu·ro·sci·ence n. Any of the sciences, such as neuroanatomy and neurobiology, that deal with the nervous system. neuroscience the embryology, anatomy, physiology, biochemistry and pharmacology of the nervous system. , and Intracellular Transmission. About Dainippon Pharmaceutical Co., Ltd. Dainippon Pharmaceuticals develops antibacterial antibacterial /an·ti·bac·te·ri·al/ (-bak-ter´e-al) destroying or suppressing growth or reproduction of bacteria; also, an agent that does this. an·ti·bac·te·ri·al adj. , cardiovascular, and neurological drugs. Founded in 1897, the company is based in Osaka. Note: Dendrite is a registered trademark of Dendrite International, Inc. The foregoing contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The statements may be identified by such forward-looking terminology as "expect," "believe," "may," "will," "intend," "plan," and similar statements or variations. Such forward-looking statements are based on our current estimates and assumptions and involve certain significant risks and uncertainties, including: risks associated with and dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy selling cycles, product implementation cycles, customer budget cycles, and timing of revenue recognition; dependence on major customers; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; retention of key senior managers; and unique characteristics of the consumer packaged goods Noun 1. packaged goods - groceries that are packaged for sale foodstuff, grocery - (usually plural) consumer goods sold by a grocer plural, plural form - the form of a word that is used to denote more than one industry. Other important factors that should be considered are included in the company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The company assumes no obligation for updating any such forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion